Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Symptomatic unilateral sacroiliitis as a first presenting feature of IgG4-related disease with successful response to treatment after 1 year of follow-up article.

Jamnitski A, van Hall O, de Vries N, van der Valk P, Lems WF, van der Horst-Bruinsma IE.

Rheumatology (Oxford). 2017 Apr 1;56(4):670-671. doi: 10.1093/rheumatology/kew481. No abstract available.

PMID:
28039416
2.

Response to: 'The influence of inflammation in the development of subclinical atherosclerosis in psoriatic arthritis' by Gonzalez-Gay et al.

Nurmohamed MT, Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I.

Ann Rheum Dis. 2014 May;73(5):e28. doi: 10.1136/annrheumdis-2014-205174. Epub 2014 Feb 27. No abstract available.

PMID:
24577335
3.

High-density lipoprotein profiling changes in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a cohort study.

Jamnitski A, Levels JH, van den Oever IA, Nurmohamed MT.

J Rheumatol. 2013 Jun;40(6):825-30. doi: 10.3899/jrheum.121358. Epub 2013 May 1.

PMID:
23637327
4.

Comparison of long-term clinical outcome with etanercept treatment and adalimumab treatment of rheumatoid arthritis with respect to immunogenicity.

Krieckaert CL, Jamnitski A, Nurmohamed MT, Kostense PJ, Boers M, Wolbink G.

Arthritis Rheum. 2012 Dec;64(12):3850-5. doi: 10.1002/art.34680.

5.

Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review.

Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT.

Ann Rheum Dis. 2013 Feb;72(2):211-6. doi: 10.1136/annrheumdis-2011-201194. Epub 2012 Apr 24. Review. Erratum in: Ann Rheum Dis. 2013 Mar;72(3):467. McIinnes, Iain [corrected to McInnes, Iain].

PMID:
22532629
6.

Patients non-responding to etanercept obtain lower etanercept concentrations compared with responding patients.

Jamnitski A, Krieckaert CL, Nurmohamed MT, Hart MH, Dijkmans BA, Aarden L, Voskuyl AE, Wolbink GJ.

Ann Rheum Dis. 2012 Jan;71(1):88-91. doi: 10.1136/annrheumdis-2011-200184. Epub 2011 Sep 12.

PMID:
21914626
7.

Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study.

Raterman HG, Jamnitski A, Lems WF, Voskuyl AE, Dijkmans BA, Bos WH, Simsek S, Lips P, van de Stadt RJ, de Koning MH, Nurmohamed MT.

J Rheumatol. 2011 Feb;38(2):247-51. doi: 10.3899/jrheum.100488. Epub 2010 Nov 15.

PMID:
21078720
8.

The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept.

Jamnitski A, Bartelds GM, Nurmohamed MT, van Schouwenburg PA, van Schaardenburg D, Stapel SO, Dijkmans BA, Aarden L, Wolbink GJ.

Ann Rheum Dis. 2011 Feb;70(2):284-8. doi: 10.1136/ard.2010.135111. Epub 2010 Nov 10.

PMID:
21068090
9.

Prevalence of cardiovascular diseases in psoriatic arthritis resembles that of rheumatoid arthritis.

Jamnitski A, Visman IM, Peters MJ, Boers M, Dijkmans BA, Nurmohamed MT.

Ann Rheum Dis. 2011 May;70(5):875-6. doi: 10.1136/ard.2010.136499. Epub 2010 Oct 18. No abstract available.

PMID:
20956406
10.

Beneficial effect of 1-year etanercept treatment on the lipid profile in responding patients with rheumatoid arthritis: the ETRA study.

Jamnitski A, Visman IM, Peters MJ, Dijkmans BA, Voskuyl AE, Nurmohamed MT.

Ann Rheum Dis. 2010 Nov;69(11):1929-33. doi: 10.1136/ard.2009.127597. Epub 2010 May 24.

PMID:
20498216
11.

Decreased clinical response to adalimumab in ankylosing spondylitis is associated with antibody formation.

de Vries MK, Brouwer E, van der Horst-Bruinsma IE, Spoorenberg A, van Denderen JC, Jamnitski A, Nurmohamed MT, Dijkmans BA, Aarden LA, Wolbink GJ.

Ann Rheum Dis. 2009 Nov;68(11):1787-8. doi: 10.1136/ard.2009.109702. No abstract available.

PMID:
19822712
12.

Adalimumab: a new modality for Behçet's disease?

van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM.

Ann Rheum Dis. 2007 Apr;66(4):565-6. Epub 2006 Nov 23. No abstract available.

13.

[Behçet's disease and the possibilities of modern tumour necrosis factor inhibiting medication].

van Laar JA, Jamnitski A, Baarsma GS, van Daele PL, van Hagen PM.

Ned Tijdschr Geneeskd. 2006 Apr 1;150(13):705-9. Dutch. Erratum in: Ned Tijdschr Geneeskd. 2006 May 6;150(18):1044. Dosage error in article text.

PMID:
16623340

Supplemental Content

Loading ...
Support Center